The Gut Microbial Lipid Metabolite 14(15)-EpETE Inhibits Substance P Release by Targeting GCG/PKA Signaling to Relieve Cisplatin-Induced Nausea and Vomiting in Rats
The Gut Microbial Lipid Metabolite 14(15)- EpETE Inhibits Substance P Release by Targeting GCG/PKA Signaling to Relieve Cisplatin-Induced Nausea and Vomiting in Rats
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Chemotherapy-induced nausea and vomiting (CINV) is a debilitating side effect related to activation of substance P (SP). SP activation can result from dysregulation of the gut-brain axis, and also from activation of protein kinase A signaling (PKA) signaling. In this study, we connected these factors in an attempt to unveil the mechanisms underlying CINV and develop new therapeutic strategies. Female rats were injected with cisplatin (Cis) to induce pica. Fecal samples were collected before/ after injection, and subjected to lipid metabolomics analysis. In another portion of pica rats, the PKA inhibitor KT5720 was applied to investigate the involvement of PKA signaling in CINV, while fecal microbiota transplantation (FMT) was implemented to verify the therapeutic effect of the lipid metabolite 14(15)-EpETE. Pica symptoms were recorded, followed by ileal histological examination. The targeting relationship between 14(15)-EpETE and glucagon was determined by bioinformatics. SP and glucagon/PKA signaling in rat ileum, serum, and/or brain substantia nigra were detected by immunohistochemistry, enzyme-linked immunosorbent assay, and/or western blot. The results showed a significantly lower level of 14(15)-EpETE in rat feces after Cis injection. KT5720 treatment alleviated Cis-induced pica symptoms, ileal injury, SP content increase in the ileum, serum, and brain substantia nigra, and ileal PKA activation in rats. The ileal level of glucagon was elevated by Cis in rats. FMT exerted an effect similar to that of KT5720 treatment, relieving the Cis-induced changes, including ileal glucagon/PKA activation in rats. Our findings demonstrate that FMT restores 14(15)-EpETE production, which inhibits SP release by targeting GCG/PKA signaling, ultimately mitigating CINV.
Abstract
Chemotherapy-induced nausea and vomiting (CINV) is a debilitating side effect related to activation of substance P (SP). SP activation can result from dysregulation of the gut-brain axis, and also from activation of protein kinase A signaling (PKA) signaling. In this study, we connected these factors in an attempt to unveil the mechanisms underlying CINV and develop new therapeutic strategies. Female rats were injected with cisplatin (Cis) to induce pica. Fecal samples were collected before/ after injection, and subjected to lipid metabolomics analysis. In another portion of pica rats, the PKA inhibitor KT5720 was applied to investigate the involvement of PKA signaling in CINV, while fecal microbiota transplantation (FMT) was implemented to verify the therapeutic effect of the lipid metabolite 14(15)-EpETE. Pica symptoms were recorded, followed by ileal histological examination. The targeting relationship between 14(15)-EpETE and glucagon was determined by bioinformatics. SP and glucagon/PKA signaling in rat ileum, serum, and/or brain substantia nigra were detected by immunohistochemistry, enzyme-linked immunosorbent assay, and/or western blot. The results showed a significantly lower level of 14(15)-EpETE in rat feces after Cis injection. KT5720 treatment alleviated Cis-induced pica symptoms, ileal injury, SP content increase in the ileum, serum, and brain substantia nigra, and ileal PKA activation in rats. The ileal level of glucagon was elevated by Cis in rats. FMT exerted an effect similar to that of KT5720 treatment, relieving the Cis-induced changes, including ileal glucagon/PKA activation in rats. Our findings demonstrate that FMT restores 14(15)-EpETE production, which inhibits SP release by targeting GCG/PKA signaling, ultimately mitigating CINV.
참고문헌 (32)
- Gupta K, "Chemotherapy-induced nausea and vomiting : pathogenesis, recommendations, and new trends", Cancer Treat Res. Commun, 26, pp.100278~ (2021)
- Zhang J, "Cisplatin chemotherapy and renal function", Adv. Cancer Res, 152, pp.305~327 (2021)
- Lugones Y, "Cisplatin resistance : genetic and epigenetic factors involved", Biomolecules, 24, pp.12~ (2022)
- Hata A, "Randomized, double-blind, phase III study of fosnetupitant versus fosaprepitant for prevention of highly emetogenic chemotherapy-induced nausea and vomiting : CONSOLE", J. Clin. Oncol, 40, pp.180~188 (2022)
- Heckroth M, "Nausea and vomiting in 2021 : a comprehensive update", J. Clin. Gastroenterol, 55, pp.279~299 (2021)
- Zhong W, "Mechanisms of nausea and vomiting : current knowledge and recent advances in intracellular emetic signaling systems", Int. J. Mol. Sci, 28, pp.22~ (2021)
- Zhao X, "Combination of thalidomide and Clostridium butyricum relieves chemotherapy-induced nausea and vomiting via gut microbiota and vagus nerve activity modulation", Front. Immunol, 14, pp.1220165~ (2023)
- Tsuge K, "Molecular mechanisms underlying prostaglandin E2-exacerbated inflammation and immune diseases", Int. Immunol, 31, pp.597~606 (2019)
- Darmani NA, "Mechanisms of broad-spectrum antiemetic efficacy of cannabinoids against chemotherapy-induced acute and delayed vomiting", Pharmaceuticals(Basel), 3, pp.2930~2955 (2010)
- Xu C, "FADS1-arachidonic acid axis enhances arachidonic acid metabolism by altering intestinal microecology in colorectal cancer", Nat. Commun, 14, pp.2042~ (2023)
- Hennebelle M, "Altered soluble epoxide hydrolase-derived oxylipins in patients with seasonal major depression : an exploratory study", Psychiatry Res, 2252, pp.94~101 (2017)
- Wang C, "Hydroxyeicosapentaenoic acids and epoxyeicosatetraenoic acids attenuate early occurrence of nonalcoholic fatty liver disease", Br. J. Pharmacol, 174, pp.2358~2372 (2017)
- Propper DJ, "Phase I study of the novel cyclic AMP(cAMP)analogue 8-chloro-cAMP in patients with cancer : toxicity, hormonal, and immunological effects", Clin. Cancer Res, 5, pp.1682~1689 (1999)
- Wu H, "Upregulation of substance P receptor expression by calcitonin gene-related peptide, a possible cooperative action of two neuropeptides involved in airway inflammation", Pulm. Pharmacol. Ther, 20, pp.513~524 (2007)
- Chen W, "cAMP signaling through protein kinase A and Epac2 induces substance P release in the rat spinal cord", Neuropharmacology, 189, pp.108533~ (2021)
- Cai T, "Therapeutic effect of fecal microbiota transplantation on chronic unpredictable mild stress-induced depression", Front. Cell. Infect. Microbiol, 12, pp.900652~ (2022)
- Chen D, "Liujunanwei decoction attenuates cisplatin-induced nausea and vomiting in a rat-pica model partially mediated by modulating the gut micsrobiome", Front. Cell. Infect. Microbiol, 12, pp.876781~ (2022)
- Huang N, "The quantitative profiling of oxylipins from arachidonic acid by LC-MS", MS in feces at birth 3 days and 21 days of piglets, 2022, pp.28, 12~
- Blackwood BP, "A role for cAMP and protein kinase A in experimental necrotizing enterocolitis", Am. J. Pathol, 187, pp.401~417 (2017)
- Horn CC, "Chemotherapy-induced kaolin intake is increased by lesion of the lateral parabrachial nucleus of the rat", Am. J. Physiol. Regul. Integr. Comp. Physiol, 297, pp.R1375~R1382 (2009)
- Schoeler M, "Dietary lipids, gut microbiota and lipid metabolism", Rev. Endocr. Metab. Disord, 20, pp.461~472 (2019)
- He Y, "Chemotherapy-induced gastrointestinal toxicity : pathogenesis and current management", Biochem. Pharmacol, 216, pp.115787~ (2023)
- Shojima Y, "Eicosapentaenoic-to-arachidonic acid ratio predicts mortality and recurrent vascular events in ischemic stroke patients", J. Atheroscler. Thromb, 27, pp.969~977 (2020)
- Wu T, "Probiotics interact with lipids metabolism and affect gut health", Front. Nutr, 9, pp.917043~ (2022)
- Wang T, "Arachidonic acid metabolism and kidney inflammation", Int. J. Mol. Sci, 27, pp.20~ (2019)
- Calder PC, "Omega-3 fatty acids and inflammatory processes", Nutrients, 2, pp.355~374 (2010)
- Zeigerer A, "Glucagon's metabolic action in health and disease", Compr. Physiol, 11, pp.1759~1783 (2021)
- Ramakrishnan SK, "HIF2α is an essential molecular brake for postprandial hepatic glucagon response independent of insulin signaling", Cell Metab, 23, pp.505~516 (2016)
- Carpenter DO, "Excitation of area postrema neurons by transmitters, peptides, and cyclic nucleotides", J. Neurophysiol, 59, pp.358~369 (1998)
- Mori F, "The human area postrema and other nuclei related to the emetic reflex express cAMP phosphodiesterases 4B and 4D", J. Chem. Neuroanat, 40, pp.36~42 (2010)
- Singh K, "Perturbations in endocytotic and apoptotic pathways are associated with chemotherapy-induced nausea", Biol. Res. Nurs, 223, pp.238~247 (2021)
- Fu Y, "Associations among dietary omega-3 polyunsaturated fatty acids, the gut microbiota, and intestinal immunity", Mediators Inflamm, 2021, pp.8879227~ (2021)